Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06512064 · ClinicalTrials.gov registry record · NA
Acoustic Waveform Respiratory Evaluation
A NA study of Asthma and Cystic Fibrosis, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 2
- Study locations
NCT06512064: Recruiting NA study of Asthma and Cystic Fibrosis, sponsored by Indiana University.
NCT06512064 is a NA study of Asthma and Cystic Fibrosis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 800 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (49% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06512064, a NA study of Asthma and Cystic Fibrosis, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
Primary Outcome
Ability of AWARE to accurately classify subjects into the study disease categories with high accuracy (\>80% sensitivity and \>80% overall accuracy)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST AWARE
Study Locations (2)
Indiana
- Indiana University - Indianapolis
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2029-04 |
| Phase | NA |
What NCT06512064 shows while recruiting
NCT06512064 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (49% lower).
The record links to 7 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which AWARE is the first listed.
NCT06512064 reports a single indexed study location in Indiana, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06512064 about?
NCT06512064 is a clinical study titled "Acoustic Waveform Respiratory Evaluation". The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
What is the current status of trial NCT06512064?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2024-07-23. Estimated completion is 2029-04.
What conditions does trial NCT06512064 study?
This clinical trial studies the following conditions: Asthma, Cystic Fibrosis, COPD, Bronchiectasis, Healthy Control.
What interventions are being tested in trial NCT06512064?
The interventions under investigation include: AWARE (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06512064?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06512064 being conducted?
This trial has 2 study locations across Indiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06512064's enrollment target sits among peer trials
800 55th of 374 higher than 320 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI